BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37951931)

  • 1. Subjective cognitive complaints and blood biomarkers of neurodegenerative diseases: a longitudinal cohort study.
    Perna L; Stocker H; Burow L; Beyer L; Trares K; Kurz C; Gürsel S; Holleczek B; Tatò M; Beyreuther K; Mons U; Gerwert K; Perneczky R; Schöttker B; Brenner H
    Alzheimers Res Ther; 2023 Nov; 15(1):198. PubMed ID: 37951931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High cholesterol levels change the association of biomarkers of neurodegenerative diseases with dementia risk: Findings from a population-based cohort.
    Perna L; Mons U; Stocker H; Beyer L; Beyreuther K; Trares K; Holleczek B; Schöttker B; Perneczky R; Gerwert K; Brenner H
    Alzheimers Dement; 2023 Jul; 19(7):2913-2922. PubMed ID: 36638231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.
    Chatterjee P; Pedrini S; Doecke JD; Thota R; Villemagne VL; Doré V; Singh AK; Wang P; Rainey-Smith S; Fowler C; Taddei K; Sohrabi HR; Molloy MP; Ames D; Maruff P; Rowe CC; Masters CL; Martins RN;
    Alzheimers Dement; 2023 Apr; 19(4):1117-1134. PubMed ID: 36574591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Performance and Clinical Applicability of Blood-Based Biomarkers in a Prospective Memory Clinic Cohort.
    Sarto J; Ruiz-García R; Guillén N; Ramos-Campoy Ó; Falgàs N; Esteller D; Contador J; Fernández G; González Y; Tort-Merino A; Juncà-Parella J; Bosch B; Borrego-Écija S; Molina-Porcel L; Castellví M; Vergara M; Antonell A; Augé JM; Naranjo L; Sanchez-Valle R; Lladó A; Balasa M
    Neurology; 2023 Feb; 100(8):e860-e873. PubMed ID: 36450604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.
    Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Lantero Rodríguez J; Snellman A; Suárez-Calvet M; Blennow K; Zetterberg H; Schöll M;
    JAMA Neurol; 2021 Apr; 78(4):396-406. PubMed ID: 33427873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease.
    Chatterjee P; Pedrini S; Ashton NJ; Tegg M; Goozee K; Singh AK; Karikari TK; Simrén J; Vanmechelen E; Armstrong NJ; Hone E; Asih PR; Taddei K; Doré V; Villemagne VL; Sohrabi HR; Zetterberg H; Masters CL; Blennow K; Martins RN
    Alzheimers Dement; 2022 Jun; 18(6):1141-1154. PubMed ID: 34494715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
    Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's polygenic risk scores, APOE, Alzheimer's disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years.
    Stocker H; Trares K; Beyer L; Perna L; Rujescu D; Holleczek B; Beyreuther K; Gerwert K; Schöttker B; Brenner H
    Alzheimers Res Ther; 2023 Jul; 15(1):129. PubMed ID: 37516890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative Disease Research Initiative.
    Sanchez E; Wilkinson T; Coughlan G; Mirza S; Baril AA; Ramirez J; Binns MA; Black SE; Borrie M; Dilliott AA; Dixon RA; Dowlatshahi D; Farhan S; Finger E; Fischer CE; Frank A; Freedman M; Goncalves RA; Grimes DA; Hassan A; Hegele RA; Kumar S; Lang AE; Marras C; McLaughlin PM; Orange JB; Pasternak SH; Pollock BG; Rajji TK; Roberts AC; Robinson JF; Rogaeva E; Sahlas DJ; Saposnik G; Strong MJ; Swartz RH; Tang-Wai DF; Tartaglia MC; Troyer AK; Kvartsberg H; Zetterberg H; Munoz DP; ; Masellis M
    Alzheimers Dement; 2024 Mar; 20(3):1753-1770. PubMed ID: 38105605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
    de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
    Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma biomarkers identify older adults at risk of Alzheimer's disease and related dementias in a real-world population-based cohort.
    Ferreira PCL; Zhang Y; Snitz B; Chang CH; Bellaver B; Jacobsen E; Kamboh MI; Zetterberg H; Blennow K; Pascoal TA; Villemagne VL; Ganguli M; Karikari TK
    Alzheimers Dement; 2023 Oct; 19(10):4507-4519. PubMed ID: 36876954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Kidney Function With Development of Alzheimer Disease and Other Dementias and Dementia-Related Blood Biomarkers.
    Stocker H; Beyer L; Trares K; Perna L; Rujescu D; Holleczek B; Beyreuther K; Gerwert K; Schöttker B; Brenner H
    JAMA Netw Open; 2023 Jan; 6(1):e2252387. PubMed ID: 36692879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOE ε4 carrier status modifies plasma p-tau181 concentrations in cognitively healthy super-seniors.
    Cooper JG; Ghodsi M; Stukas S; Leach S; Brooks-Wilson A; Wellington CL
    Alzheimers Dement; 2024 Jun; 20(6):4373-4380. PubMed ID: 38752508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy.
    Chouliaras L; Thomas A; Malpetti M; Donaghy P; Kane J; Mak E; Savulich G; Prats-Sedano MA; Heslegrave AJ; Zetterberg H; Su L; Rowe JB; O'Brien JT
    J Neurol Neurosurg Psychiatry; 2022 Jun; 93(6):651-658. PubMed ID: 35078917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations Between Blood-Based Biomarkers and Cognitive and Functional Trajectories Among Participants of the MEMENTO Cohort.
    Grasset L; Bouteloup V; Cacciamani F; Pellegrin I; Planche V; Chêne G; Dufouil C;
    Neurology; 2024 May; 102(9):e209307. PubMed ID: 38626384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of plasma phosphorylated tau181 and neurofilament light chain with brain amyloid burden and cognition in objectively defined subtle cognitive decline patients.
    Huang Y; Li Y; Xie F; Guo Q
    CNS Neurosci Ther; 2022 Dec; 28(12):2195-2205. PubMed ID: 36074638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood biomarkers in mild cognitive impairment patients: Relationship between analytes and progression to Alzheimer disease dementia.
    Silva-Spínola A; Lima M; Leitão MJ; Bernardes C; Durães J; Duro D; Tábuas-Pereira M; Santana I; Baldeiras I
    Eur J Neurol; 2023 Jun; 30(6):1565-1573. PubMed ID: 36880887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias.
    Baiardi S; Quadalti C; Mammana A; Dellavalle S; Zenesini C; Sambati L; Pantieri R; Polischi B; Romano L; Suffritti M; Bentivenga GM; Randi V; Stanzani-Maserati M; Capellari S; Parchi P
    Alzheimers Res Ther; 2022 Oct; 14(1):153. PubMed ID: 36221099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
    Smith R; Strandberg O; Mattsson-Carlgren N; Leuzy A; Palmqvist S; Pontecorvo MJ; Devous MD; Ossenkoppele R; Hansson O
    Brain; 2020 Dec; 143(12):3805-3815. PubMed ID: 33439987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.